We thank the Swiss National Science Foundation for support (Projects 200021-115918/1 (K.G.) and 3100A0-101712 (U.K.)), as well as the Latsis Foundation. This work is part of the planned PhD thesis of S.B. at ETH Zürich. We thank Dr. B. Schweizer and Dr. R. Scopelliti for X-ray structural analyses.
Communication
Total Synthesis, Configuration, and Biological Evaluation of Anguinomycin C†
Article first published online: 4 OCT 2007
DOI: 10.1002/anie.200703134
Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Issue

Angewandte Chemie International Edition
Volume 46, Issue 45, pages 8707–8710, November 19, 2007
Additional Information
How to Cite
Bonazzi, S., Güttinger, S., Zemp, I., Kutay, U. and Gademann, K. (2007), Total Synthesis, Configuration, and Biological Evaluation of Anguinomycin C. Angew. Chem. Int. Ed., 46: 8707–8710. doi: 10.1002/anie.200703134
- †
Publication History
- Issue published online: 8 NOV 2007
- Article first published online: 4 OCT 2007
- Manuscript Received: 13 JUL 2007
Funded by
- Swiss National Science Foundation. Grant Numbers: 200021-115918/1, 3100A0-101712
Keywords:
- antitumor agents;
- leptomycins;
- nuclear export;
- polyketides;
- total synthesis

Against nuclear export! Immunofluorescence assays indicate that anguinomycin C is a potent inhibitor of protein export from the nucleus. Key features in the total synthesis of this antitumor natural product include a Cr-catalyzed enantioselective hetero-Diels–Alder reaction, a Negishi reaction with stereoinversion, and application of the DIOZ auxiliary.

1521-3773/asset/2002_left.gif?v=1&s=ac6b0d94a94d7ce7a210002b8096b42feffc0bcf)
1521-3773/asset/2002_right.gif?v=1&s=451042aa3415ae3ad0729984d26dee1866aca82e)